Abstract:ConspectusAllostery, or allosteric regulation, is the phenomenon in which protein functional activity is altered by the binding of an effector at an allosteric site that is topographically distinct from the orthosteric, active site. As one of the most direct and efficient ways to regulate protein function, allostery has played a fundamental role in innumerable biological processes of all living organisms, including enzyme catalysis, signal transduction, cell metabolism, and gene transcription. It is thus considered as "the second secret of life". The abnormality of allosteric communication networks between allosteric and orthosteric sites is associated with the pathogenesis of human diseases. Allosteric modulators, by attaching to structurally diverse allosteric sites, offer the potential for differential selectivity and improved safety compared with orthosteric drugs that bind to conserved orthosteric sites. Harnessing allostery has thus been regarded as a novel strategy for drug discovery.Despite much progress having been made in the repertoire of allostery since the turn of the millennium, the identification of allosteric drugs for therapeutic targets and the elucidation of allosteric mechanisms still present substantial challenges. These challenges are derived from the difficulties in the identification of allosteric sites and mutations, the assessment of allosteric protein–modulator interactions, the screening of allosteric modulators, and the elucidation of allosteric mechanisms in biological systems.To address these issues, we have developed a panel of allosteric services for specific allosteric applications over the past decade, including (i) the creation of the Allosteric Database, with the aim of providing comprehensive allosteric information such as allosteric proteins, modulators, sites, pathways, etc., (ii) the construction of the ASBench benchmark of high-quality allosteric sites for the development of computational methods for predicting allosteric sites, (iii) the development of Allosite and AllositePro for the prediction of the location of allosteric sites in proteins, (iv) the development of the Alloscore scoring function for the evaluation of allosteric protein–modulator interactions, (v) the development of Allosterome for evolutionary analysis of query allosteric sites/modulators within the human proteome, (vi) the development of AlloDriver for the prediction of allosteric mutagenesis, and (vii) the development of AlloFinder for the virtual screening of allosteric modulators and the investigation of allosteric mechanisms. Importantly, we have validated computationally predicted allosteric sites, mutations, and modulators in the real cases of sirtuin 6, casein kinase 2α, phosphodiesterase 10A, and signal transduction and activation of transcription 3. Furthermore, our developed allosteric methods have been widely exploited by other users around the world for allosteric research. Therefore, these allosteric services are expected to expedite the discovery of allosteric drugs and the investigation of allosteric mechanisms.

Toward understanding the molecular basis for chemical allosteric modulator design

A Structure-based Allosteric Modulator Design Paradigm

Allosteric Modulator Discovery: from Serendipity to Structure-Based Design.

Toward an Understanding of the Sequence and Structural Basis of Allosteric Proteins.

Computational elucidation of allosteric communication in proteins for allosteric drug design

Rational design of allosteric modulators: Challenges and successes

Along the allostery stream: Recent advances in computational methods for allosteric drug discovery

Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design

Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.

Toward the Design of Allosteric Effectors: Gaining Comprehensive Control of Drug Properties and Actions

Allosteric Regulation at the Crossroads of New Technologies: Multiscale Modeling, Networks, and Machine Learning

Harnessing Allostery: a Novel Approach to Drug Discovery.

Allosteric Type and Pathways Are Governed by the Forces of Protein-Ligand Binding

Molecular Insights into Ago-Allosteric Modulation of the Human Glucagon-Like Peptide-1 Receptor

Covalent allosteric modulation: An emerging strategy for GPCRs drug discovery

Recent Computational Advances in the Identification of Allosteric Sites in Proteins

Integrated in Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5

Allosteric Modulation of Ligand-gated Ion Channel Receptor

Characteristics of Allosteric Proteins, Sites, and Modulators.

Protein Allostery in Drug Discovery

Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms